1. HDAC Screening Identifies the HDAC Class I Inhibitor Romidepsin as a Promising Epigenetic Drug for Biliary Tract Cancer
   Christian Mayr et al, 2021, Cancers CrossRef
2. Histone Deacetylase Inhibitors and Phenotypical Transformation of Cancer Cells
   Anna Wawruszak et al, 2019, Cancers CrossRef
3. Chidamide Suppresses the Growth of Cholangiocarcinoma by Inhibiting HDAC3 and Promoting FOXO1 Acetylation
   Yongpan Li et al, 2022, Stem Cells International CrossRef
4. The role of protein acetylation in carcinogenesis and targeted drug discovery
   Jingru Yang et al, 2022, Frontiers in Endocrinology CrossRef
5. The Investigative Therapeutic Pipeline for Cholangiocarcinoma: Insights from Model Systems
   Luca Maroni et al, 2021, Diagnosis and Management of Cholangiocarcinoma CrossRef
6. Molecular Regulators of Cellular Mechanoadaptation at Cell–Material Interfaces
   Juhyeon Jo et al, 2020, Frontiers in Bioengineering and Biotechnology CrossRef